$1.92
-0.11-5.42%
Last update: Oct 30, 7:58 PM
DataMEDS AI Inc (MEDS) Stock Price, Quote, News & History
MEDSNASDAQ
Humana includes DataMeds AI's Helomics ChemoFx assay in its Medicaid policy for gynecologic cancers, expanding payer reimbursement.
You can purchase shares of DataMEDS AI (NASDAQ:MEDS) through any online brokerage.
Other companies in DataMEDS AI’s space includes: McKesson Corp (NYSE:MCK), Cencora Inc (NYSE:COR), Cardinal Health Inc (NYSE:CAH), Henry Schein Inc (NASDAQ:HSIC) and AdaptHealth Corp (NASDAQ:AHCO).
There is no analysis for DataMEDS AI to provide a consensus price target.
The stock price for DataMEDS AI (NASDAQ: MEDS) is $1.87 last updated October 30, 2026 at 7:58 PM EDT.
There are no upcoming dividends for DataMEDS AI.
DataMEDS AI does not have any upcoming earnings scheduled.
There is no upcoming split for DataMEDS AI.
DataMEDS AI is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for...
